SCHEMBL8265891

SCHEMBL8265891

CC(C)N(C(=O)c1cnc(N2CCNCC2)nc1C1=C(F)CCC=C1)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 17/20 0.38
▸ ALDH1A1 P00352 16/20 0.38
▸ HSD17B10 Q99714 16/20 0.38
▸ CYP3A4 P08684 15/20 0.38
▸ HIF1A Q16665 14/20 0.38
▸ CASP1 P29466 13/20 0.38
▸ CASP7 P55210 13/20 0.38
▸ USP2 O75604 13/20 0.38
▸ CYP2C19 P33261 9/20 0.38
▸ TP53 P04637 5/20 0.38
▸ MAPK1 P28482 4/20 0.38
▸ TSHR P16473 4/20 0.38
▸ LMNA P02545 3/20 0.38
▸ CYP2C9 P11712 11/20 0.37
▸ HPGD P15428 9/20 0.37
▸ GLA P06280 3/20 0.37
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ CLK4 Q9HAZ1 1/20 0.35
▸ CYP2D6 P10635 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8268303 0.90 PTPN11 (0.40) HSD17B10PTPN11
SCHEMBL8266187 0.82 MAPT (0.37) CYP1A2ALDH1A1HSD17B10CYP3A4HIF1A
SCHEMBL8267721 0.80 PIK3R1 (0.35) CYP1A2ALDH1A1HSD17B10CYP3A4HIF1A
SCHEMBL8267735 0.78 POLB (0.36) CASP1LMNASMN1; SMN2
SCHEMBL11923230 0.73 PTPN11 (0.40) ALDH1A1HIF1ATP53LMNASMN1; SMN2
SCHEMBL11923180 0.73 TACR1 (0.49) CYP1A2ALDH1A1HSD17B10CYP3A4HIF1A
SCHEMBL8266025 0.72 MEN1 (0.33) ALDH1A1CYP3A4USP2CYP2C19TP53
SCHEMBL11923296 0.72 PTPN11 (0.43) ALDH1A1HSD17B10TSHRHPGDSMN1; SMN2
SCHEMBL11923223 0.72 PTPN11 (0.43) CYP1A2ALDH1A1HSD17B10CYP3A4HIF1A
SCHEMBL8267771 0.72 CYP1A2 (0.35) CYP1A2ALDH1A1HSD17B10CYP3A4HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006050476-A2 PYRIMIDINE DERIVATIVES AS ION CHANNEL MODULATORS AND METHODS OF USE VERTEX PHARMACEUTICALS INCORPORATED (US) 2006-05-11 — — WO disclosed
Send feedback